GlassScriptPhysician profile
Audrey A Gray
NPI 1952946030
$2,096.77
in general payments reported to CMS, 2019-2025
23 companies · $660 in 2025
The $660 reported for 2025 was more than what 91% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20.01 · 2022: $411 · 2023: $325 · 2024: $681 · 2025: $660.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,567 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,566.95 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $649.14 | 2024-2025 | Veozah |
| Abbvie INC. | $241.98 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $208.74 | 2023-2025 | Myfembree |
| Biogen, INC. | $208.41 | 2024-2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $138.18 | 2022-2025 | |
| Exeltis, USA INC. | $101.33 | 2021-2025 | Slynd |
| Coopersurgical, INC. | $90.67 | 2022-2025 | Paragard T 380a, Paragard T 380a |
| Myovant Sciences INC. | $73.54 | 2022 | |
| Daiichi Sankyo INC. | $57.91 | 2022-2023 | Injectafer |
| Amgen INC. | $53.97 | 2023 | Prolia |
| Hologic Sales and Service, LLC | $48.63 | 2024-2025 | Novasure, Acessa Provu System, Coolseal Generator |
| Octapharma USA, INC. | $28.83 | 2025 | Fibryga |
| Bayer Healthcare Pharmaceuticals INC. | $25.38 | 2023 | |
| Seqirus USA INC | $20.62 | 2025 | Fluad, Flucelvax |
| Merck Sharp & Dohme LLC | $20.59 | 2024 | Gardasil, Gardasil 9, Capvaxive |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $19.36 | 2022 | |
| Organon LLC | $18.86 | 2025 | Nexplanon |
| Convatec INC. | $18.39 | 2025 | |
| Medtronic, INC. | $15.54 | 2022 | |
| Lilly USA, LLC | $15.43 | 2025 | Zepbound |
| Scynexis, INC. | $15.31 | 2022 | |
| Pfizer INC. | $14.02 | 2022 | |
| Smith+Nephew, INC. | $11.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audrey Gray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.